Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Roche | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Roche | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 17 hours ago
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
about 17 hours ago
Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Interventions: Drug: Mosunetuzumab; Drug...
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mu
about 17 hours ago
Conditions: Non-Small Cell Lung Cancer Interventions: Drug: Divarasib; Drug: Pembrolizumab; Drug: Carboplatin...
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
about 17 hours ago
Conditions: Lymphoma Interventions: Drug: Glofitamab; Drug: Tocilizumab; Drug: Obinutuzumab; Drug: Gemcitabine; Drug...
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lun
about 17 hours ago
Conditions: Non-Small Cell Lung Cancer; KRAS G12C Lung Cancer Interventions: Drug: Divarasib...
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
about 17 hours ago
Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Drug: Alectinib Sponsors: Hoffmann-La Roche Recruiting
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
about 17 hours ago
Conditions: Diffuse Large B-Cell Lymphoma Interventions: Drug: Glofitamab Sponsors: Hoffmann-La Roche Recruiting
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
about 17 hours ago
Conditions: Moderately to Severely Active Crohns Disease Interventions: Drug: Afimkibart Sponsors: Hoffmann-La...
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
about 17 hours ago
Conditions: Locally Advanced Breast Cancer; Metastatic Breast Cancer Interventions: Drug: Inavolisib; Drug...
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
about 17 hours ago
Conditions: Breast Cancer Interventions: Drug: Inavolisib; Drug: Ribociclib; Drug: Fulvestrant; Drug: Placebo...
A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
about 17 hours ago
Conditions: Stable Coronary Artery Disease; Healthy Volunteers Interventions: Drug: RO7763505; Drug: Placebo...
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
3 days ago
Conditions: Solid Tumors Interventions: Drug: Entrectinib; Drug: Entrectinib; Drug: Alectinib; Drug: Atezolizumab...
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
3 days ago
Conditions: Parkinsons Disease Interventions: Drug: Prasinezumab; Drug: Placebo Sponsors: Hoffmann-La Roche; Prothena...